• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TAT 修饰胆固醇脂质体用于增强脑内递药。

Liposome formulated with TAT-modified cholesterol for enhancing the brain delivery.

机构信息

Key Laboratory of Drug Targeting and Drug Delivery Systems, West China School of Pharmacy, Sichuan University, No. 17, Block 3, Southern Renmin Road, Chengdu 610041, Sichuan, PR China.

出版信息

Int J Pharm. 2011 Oct 31;419(1-2):85-95. doi: 10.1016/j.ijpharm.2011.07.021. Epub 2011 Jul 23.

DOI:10.1016/j.ijpharm.2011.07.021
PMID:21807083
Abstract

Delivery of drugs to the brain is a major challenge due to the presence of the blood-brain barrier (BBB). The cell penetrating peptide TAT, which appears to enter cells with alacrity, can pass through the BBB efficiently. With this in mind, a novel TAT-modified liposome (TAT-LIP) was developed for overcoming the ineffective delivery of normal drug formulation to the brain. Targeting liposomal formulations are always composed of modified phospholipids as an anchor. However, cholesterol, another liposomal component, which was more stable and cheaper, has not been fully investigated as an alternative anchor. In this study, TAT was covalently conjugated with the cholesterol to prepare the liposome. The cellular uptake by brain capillary endothelial cells (BCECs) of rats and the mechanism of TAT-LIP pathway of endocytosis was explored. The blood brain barrier model in vitro was established to evaluate the transendothelial ability crossing the BBB and its transport mechanism. The biodistribution of each formulation was further identified. The results showed that the positive charge of the TAT-LIP played an important role in enhancing its brain delivery. The absorptive endocytosis might be one of the mechanisms of TAT-LIP crossing the BBB. In conclusion, the experimental data in vitro and in vivo indicated that the TAT-LIP was a promising brain drug delivery system due to its high delivery efficiency across the BBB.

摘要

向大脑输送药物是一项重大挑战,这是由于存在血脑屏障(BBB)。穿透细胞肽 TAT 似乎能够迅速进入细胞,能够有效地穿过 BBB。考虑到这一点,开发了一种新型 TAT 修饰的脂质体(TAT-LIP),以克服正常药物制剂向大脑输送的无效性。靶向脂质体制剂始终由作为锚的改性磷脂组成。然而,胆固醇是脂质体的另一个成分,它更稳定且更便宜,但尚未作为替代锚进行充分研究。在这项研究中,TAT 与胆固醇共价连接以制备脂质体。研究了 TAT-LIP 内吞作用途径的大鼠脑毛细血管内皮细胞(BCEC)摄取及其机制。建立了体外血脑屏障模型,以评估穿过 BBB 的跨内皮能力及其转运机制。进一步鉴定了每种制剂的生物分布。结果表明,TAT-LIP 的正电荷在增强其向大脑的输送中起重要作用。吸收性内吞作用可能是 TAT-LIP 穿过 BBB 的机制之一。总之,体外和体内的实验数据表明,TAT-LIP 是一种有前途的脑药物输送系统,因为它具有很高的穿过 BBB 的输送效率。

相似文献

1
Liposome formulated with TAT-modified cholesterol for enhancing the brain delivery.TAT 修饰胆固醇脂质体用于增强脑内递药。
Int J Pharm. 2011 Oct 31;419(1-2):85-95. doi: 10.1016/j.ijpharm.2011.07.021. Epub 2011 Jul 23.
2
Liposome formulated with TAT-modified cholesterol for improving brain delivery and therapeutic efficacy on brain glioma in animals.采用 TAT 修饰胆固醇的脂质体,提高脑内递药效率,增强动物脑胶质瘤的治疗效果。
Int J Pharm. 2011 Nov 28;420(2):304-12. doi: 10.1016/j.ijpharm.2011.09.008. Epub 2011 Sep 16.
3
Comparison of four different peptides to enhance accumulation of liposomes into the brain.比较四种不同的肽以增强脂质体进入大脑的积累。
J Drug Target. 2012 Apr;20(3):235-45. doi: 10.3109/1061186X.2011.639022. Epub 2011 Dec 21.
4
In vitro and in vivo investigation of glucose-mediated brain-targeting liposomes.葡萄糖介导的脑靶向脂质体的体内外研究。
J Drug Target. 2010 Aug;18(7):536-49. doi: 10.3109/10611861003587235.
5
Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.用他莫昔芬和麦胚凝集素修饰的双靶向拓扑替康脂质体可显著改善药物透过血脑屏障的运输,并提高荷脑肿瘤动物的存活率。
Mol Pharm. 2009 May-Jun;6(3):905-17. doi: 10.1021/mp800218q.
6
Lactoferrin-modified procationic liposomes as a novel drug carrier for brain delivery.乳铁蛋白修饰的前离子脂质体作为一种新型脑递药载体。
Eur J Pharm Sci. 2010 May 12;40(2):94-102. doi: 10.1016/j.ejps.2010.03.007. Epub 2010 Mar 16.
7
Targeted delivery of cargoes into a murine solid tumor by a cell-penetrating peptide and cleavable poly(ethylene glycol) comodified liposomal delivery system via systemic administration.通过全身给药,利用穿透细胞肽和可切割聚乙二醇共修饰的脂质体递药系统将货物靶向递送至小鼠实体瘤中。
Mol Pharm. 2011 Dec 5;8(6):2151-61. doi: 10.1021/mp200100f. Epub 2011 Oct 26.
8
Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the blood-brain barrier.由胆固醇封端的聚乙二醇-穿膜肽自组装而成的具有生物活性的核壳纳米颗粒用于药物跨血脑屏障递送。
Biomaterials. 2008 Apr;29(10):1509-17. doi: 10.1016/j.biomaterials.2007.11.014. Epub 2007 Dec 21.
9
Liposomes formulated with fMLP-modified cholesterol for enhancing drug concentration at inflammatory sites.用 fMLP 修饰的胆固醇制成的脂质体,用于增强炎症部位的药物浓度。
J Drug Target. 2014 Feb;22(2):165-74. doi: 10.3109/1061186X.2013.851683.
10
[Study on nerve growth factor liposomes on crossing blood-brain barrier in vitro and in vivo].神经生长因子脂质体体外及体内跨血脑屏障的研究
Yao Xue Xue Bao. 2004 Nov;39(11):944-8.

引用本文的文献

1
Nanomaterials as drug delivery agents for overcoming the blood-brain barrier: A comprehensive review.纳米材料作为克服血脑屏障的药物递送剂:综述
ADMET DMPK. 2023 Oct 31;12(1):63-105. doi: 10.5599/admet.2043. eCollection 2024.
2
Receptor-Assisted Nanotherapeutics for Overcoming the Blood-Brain Barrier.受体介导的纳米治疗克服血脑屏障。
Mol Neurobiol. 2024 Nov;61(11):8702-8738. doi: 10.1007/s12035-024-04015-9. Epub 2024 Apr 1.
3
Forging the Frontiers of Image-Guided Neurosurgery-The Emerging Uses of Theranostics in Neurosurgical Oncology.
开拓图像引导神经外科的前沿——治疗诊断学在神经外科肿瘤学中的新兴应用
Front Bioeng Biotechnol. 2022 Jul 12;10:857093. doi: 10.3389/fbioe.2022.857093. eCollection 2022.
4
P1c peptide decorated liposome targeting αvβ3-expressing tumor cells and .P1c肽修饰的脂质体靶向表达αvβ3的肿瘤细胞以及……(原文句子不完整)
RSC Adv. 2018 Jul 18;8(45):25575-25583. doi: 10.1039/c8ra05014g. eCollection 2018 Jul 16.
5
Enhanced target cell specificity and uptake of lipid nanoparticles using RNA aptamers and peptides.使用RNA适体和肽增强脂质纳米颗粒的靶细胞特异性和摄取
Beilstein J Org Chem. 2021 Apr 26;17:891-907. doi: 10.3762/bjoc.17.75. eCollection 2021.
6
Rethinking CRITID Procedure of Brain Targeting Drug Delivery: Circulation, Blood Brain Barrier Recognition, Intracellular Transport, Diseased Cell Targeting, Internalization, and Drug Release.重新思考脑靶向药物递送的 CRITID 程序:循环、血脑屏障识别、细胞内转运、病变细胞靶向、内化和药物释放。
Adv Sci (Weinh). 2021 Feb 24;8(9):2004025. doi: 10.1002/advs.202004025. eCollection 2021 May.
7
A Dual Receptor Targeting- and BBB Penetrating- Peptide Functionalized Polyethyleneimine Nanocomplex for Secretory Endostatin Gene Delivery to Malignant Glioma.一种双受体靶向和 BBB 穿透肽功能化聚乙烯亚胺纳米复合物,用于将分泌型内皮抑素基因递送至恶性脑胶质瘤。
Int J Nanomedicine. 2020 Nov 12;15:8875-8892. doi: 10.2147/IJN.S270208. eCollection 2020.
8
Development and screening of brain-targeted lipid-based nanoparticles with enhanced cell penetration and gene delivery properties.脑靶向脂质纳米粒的构建与筛选及其增强的细胞穿透和基因传递性能。
Int J Nanomedicine. 2019 Aug 14;14:6497-6517. doi: 10.2147/IJN.S215941. eCollection 2019.
9
Targeted Theranostic Nanoparticles for Brain Tumor Treatment.用于脑肿瘤治疗的靶向诊疗纳米颗粒
Pharmaceutics. 2018 Oct 9;10(4):181. doi: 10.3390/pharmaceutics10040181.
10
Liposomal formulations of carboplatin injected by convection-enhanced delivery increases the median survival time of F98 glioma bearing rats.脂质体包裹的卡铂通过对流增强递送增加了携带 F98 神经胶质瘤大鼠的中位生存时间。
J Nanobiotechnology. 2018 Oct 5;16(1):77. doi: 10.1186/s12951-018-0404-8.